Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Pavly Moawd